
NorthEdge scores first exit with Accrol IPO
Accrol Group, a UK-based tissue manufacturer backed by NorthEdge Capital, has listed on AIM with a £93m market cap.
Shares were priced at 100 pence apiece, allowing the business to raise £63.5m. Its enterprise value reached £116m. The company stated it would use the proceeds of the placing of new shares to repay all shareholder loan notes and refinance existing debt.
NorthEdge will retain a 15% stake in the company following the listing. The IPO marks the first divestment for the firm, which launched its £225m maiden fund in 2013. The GP secured a 46% stake in the business in 2014 via this maiden fund, in a deal that valued the tissue producer at £66m.
Zeus Capital brokered the IPO.
Company
Founded in 1993 and headquartered in Blackburn, Accrol manufactures soft paper products such as kitchen towels, toilet rolls, napkins and facial tissues. The company supplies both the branded and private label sectors.
According to publicly available information, Accrol generated a £101m turnover in 2014/15, with EBITDA of £10m.
People
NorthEdge Capital – Dan Wright (COO).
Accrol Group – Majid Hussain (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater